BUSINESS BITES: Endeavour Eyes More Medtech Plays; M3i Puts Yen In Artificial Heart; Curetis Makes Third mDx Launch
This article was originally published in Clinica
Endeavour Vision’s fund, Endeavour Medtech Growth LP (EMG), is looking to invest in “high potential” European and US medical device and digital health companies that are starting to take their first steps to commercialize their approved products. Endeavour raised €250m ($275m) for EMG, said to be “the largest fund dedicated to medtech in Europe and one of the largest pure medtech funds worldwide.” The fund will allocate between €10-20m per investment.
You may also be interested in...
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.